1. Resource utilization and cost effectiveness of treating acute promyelocytic leukaemia using generic arsenic trioxide. (21st December 2019) Authors: Bankar, Aniket; Korula, Anu; Kulkarni, Uday P.; Devasia, Anup J.; NA, Fouzia; Lionel, Sharon; Abraham, Aby; Balasubramanian, Poonkuzhali; Janet, Nancy Beryl; Nair, Sukesh C.; S, Sezlian; Jeyaseelan, Visali; N, Jeyaseelan; Prasad, Jasmine; George, Biju; Mathews, Vikram Journal: British journal of haematology Issue: Volume 189:Number 2(2020) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study. (15th June 2021) Authors: Bankar, Aniket; Alibhai, Shabbir; Smith, Elliot; Yang, Dongyang; Malik, Sarah; Cheung, Verna; Siddiq, Nancy; Claudio, Jaime; Arruda, Andrea; Tsui, Hubert; Capo‐Chichi, Jose‐Mario; Kennedy, James A.; McNamara, Caroline; Sibai, Hassan; Maze, Dawn; Xu, Wei; Gupta, Vikas Journal: British journal of haematology Issue: Volume 194:Number 3(2021) Page Start: 557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An evaluation of no‐treatment decisions in patients with newly diagnosed acute myeloid leukemia. Issue 1 (23rd October 2020) Authors: Brandwein, Joseph M.; Hallett, Darren; Karkhaneh, Mohammad; Zhu, Nancy; Liew, Elena; Bolster, Lauren; Hamilton, Marlene; Patterson, Jeffrey; Taparia, Minakshi; Wu, Cynthia; Van Slyke, Tiffany; Bankar, Aniket; Saini, Lalit Journal: American journal of hematology Issue: Volume 96:Issue 1(2021) Page Start: E17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association of creatine kinase elevation with clinical outcomes in chronic myeloid leukemia: a retrospective cohort study. Issue 1 (2nd January 2022) Authors: Bankar, Aniket; Lipton, Jeffrey H. Journal: Leukemia & lymphoma Issue: Volume 63:Issue 1(2022) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Investigational non-JAK inhibitors for chronic phase myelofibrosis. (3rd May 2020) Authors: Bankar, Aniket; Gupta, Vikas Journal: Expert opinion on investigational drugs Issue: Volume 29:Number 5(2020) Page Start: 461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada. Issue 8 (2nd July 2020) Authors: Bankar, Aniket; Zhao, Haoyu; Iqbal, Javaid; Coxford, Ruth; Cheung, Matthew C.; Mozessohn, Lee; Earle, Craig C.; Gupta, Vikas Journal: Leukemia & lymphoma Issue: Volume 61:Issue 8(2020) Page Start: 1908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first‐line JAK‐inhibitor. Issue 5 (7th March 2023) Authors: England, James T.; Atenafu, Eshetu G.; Kennedy, James A.; Goraya, Burhan; Cheung, Verna; Nye, Taylor; Gauthier, Karine; Davidson, Marta B.; Bankar, Aniket; Sibai, Hassan; Maze, Dawn; Viswabandya, Auro; Gupta, Vikas Journal: American journal of hematology Issue: Volume 98:Issue 5(2023) Page Start: E127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Investigational non-JAK inhibitors for chronic phase myelofibrosis. (3rd May 2020) Authors: Bankar, Aniket; Gupta, Vikas Journal: Expert opinion on investigational drugs Issue: Volume 29:Number 5(2020) Page Start: 461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗